MoneyWorks4Me

Gland Pharma informs about analyst meet

13 Jun 2022 Evaluate

Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it enclosed schedule of Analyst/ Institutional Investor Meetings with the Company. The schedule of the above-mentioned meetings is subject to change and the change may occur due to exigencies on the part of the Investor/ Analyst/ Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.00
Dr. Reddys Labs. 1226.95
Cipla 1305.50
Lupin 1944.90
Zydus Lifesciences 1123.00
View more..